Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clostridium butyricum + PD-1 inhibitor in bladder cancer
NCT06696742Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Feb 2024
- Primary completion
- Feb 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of clostridium butyricum in bladder cancer, sponsored by Jiangsu Provincial People's Hospital. Started Feb 2024; status: recruiting.
02
Drugs
clostridium butyricum
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT06696742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06696742.